SavaSeniorCare to drop 48 facilities, aims to increase worker pay and benefits
By
Danielle Brown
Nov 04, 2020
In a bid to boost employee pay and benefits, hire infection preventionists and invest more in doctors, technology and equipment, SavaSeniorCare on Tuesday announced it will be acting to get out of 48 skilled...
HHS halts Eli Lilly’s single-drug COVID antibody treatment in U.S.; dual-drug alternative remains in...
By
Alicia Lasek
Mar 26, 2021
U.S. distribution of an infusion treatment using bamlanivimab only has been halted due to virus variant concerns, but an alternative antibody cocktail from the drugmaker can still be ordered, according...
Certain populations to receive Paxlovid free through 2024, under new agreement
By
Kristen Fischer
Oct 17, 2023
Paxlovid, an oral drug that treats COVID-19, will begin to enter the commercial market starting next month. At the same time, the US federal government is making sure that the country has enough supply,...
Study seeks to shed light on COVID-19’s impact on the brain
By
John Roszkowski
Sep 23, 2022
A global consortium of researchers is seeking to uncover the short-term and long-term impacts of COVID-19 on the brain to assess whether it can lead to cognitive impairments later in life such as Alzheimer’s...
FDA set to approve two COVID-19 antiviral pills this week
By
Alicia Lasek
Dec 22, 2021
FDA is expected to grant emergency use authorization to two antiviral COVID-19 pills this week, possibly as early as today, according to Bloomberg News, citing sources familiar with the matter.
Pirola COVID-19 variant may not be as contagious as previous variants, researchers say
By
Kristen Fischer
Sep 06, 2023
A new report finds that a new COVID-19 variant — BA.2.86, or Pirola — may not be as contagious than originally thought. That’s good news for long-term care communities, who have been told to brace...
Pandemic lessons learned need to apply to future dementia care in nursing homes: editorial
By
Kristen Fischer
Feb 02, 2024
An editorial in response to a 2023 study about caring for people with dementia during the pandemic highlights some of the ongoing issues in nursing home care quality that became prominent during the outbreak...
FDA no longer requires positive COVID-19 test to prescribe Paxlovid, Lagevrio
By
Alicia Lasek
Feb 01, 2023
The FDA on Wednesday made it easier for clinicians to prescribe these antiviral drugs in cases where transmission is evident and the patient is at high risk of severe illness.
AARP: 4 years later, COVID-19 still rages in nursing homes
By
Kristen Fischer
Mar 18, 2024
Even as nursing home cases and deaths related to COVID-19 are declining, a recent analysis finds the virus is still wreaking havoc in long-term care settings.
Feds halt an Eli Lilly antibody therapy in 3 states due to variant fears, while boosting the treatment...
By
Alicia Lasek
Mar 19, 2021
A COVID-19 variant circulating widely in California, Arizona and Nevada has rendered bamlanivimab alone ineffective, an FDA official reports. But Lilly says an approved alternative treatment “maintains...